Clinical Trial: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma

Sponsor and Collaborators
Duke University
Celgene Corporation

Contact
Contact: Donna Adams, ANP
(919) 668-4716
adams068@mc.duke.edu

Contact: Patricia Davis, RN
(919) 668-1026
davis043@mc.duke.edu


Continue Reading

Principal Investigator
Anne W. Beaven, MD Duke University Medical Center Durham, NC USA

ClinicalTrials.gov Identifier

NCT01121757